New study targets lingering concussion symptoms in teens

NCT ID NCT05446597

Completed Symptom relief Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three different treatment approaches for teens aged 13-19 who had a concussion within the past three weeks and were still experiencing moderate to severe symptoms like headaches, dizziness, and neck pain. The goal was to see if early, symptom-specific treatments could reduce symptom burden and speed up return to normal activities. The trial compared a headache-focused nerve block, a dizziness/neck pain physiotherapy program, and a general 'lite' combination of advice and relaxation techniques.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Greater Occipital Nerve Block, cervicovestibular physiotherapy, and a lite combination of headache advice, general physiotherapy, mindfulness, visualization, and relaxation
What this could lead to: If successful, this could point toward better, personalized treatment plans for teens recovering from concussion, reducing long-term symptoms.
What could go wrong: This is a small, completed trial with only 62 participants, so results may not apply to all teens. The treatments are early-stage and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIZZINESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion Dizziness Neck Pain Post-Traumatic Headache traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIZZINESS HEADACHES POSTTRAUMATIC MILD TRAUMATIC BRAIN INJURY NECK PAIN

Contacts and locations

Locations

University of Calgary

Calgary, Alberta, T2N 1N4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.